A phase II study of a gene-modified vaccinia virus expressing MUC1 and IL-2 (TG1031) in patients with metastatic breast cancer

2001 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []